Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$120 Mln
Revenue (TTM)
$235 Mln
Net Profit (TTM)
$-549 Mln
ROE
-0.6 %
ROCE
-- %
P/E Ratio
1.6
P/B Ratio
0.2
Industry P/E
--
EV/EBITDA
-0
Div. Yield
0 %
Debt to Equity
--
Book Value
$0.7
EPS
$-1.6
Face value
--
Shares outstanding
386,795,008
CFO
$-646.13 Mln
EBITDA
$-243.45 Mln
Net Profit
$-824.27 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sema4 Holdings Corp. Class A (SMFR)
| 37.9 | -9.9 | 30.9 | -87.2 | -- | -- | -- |
|
BSE Sensex*
| -13.5 | -9.9 | -14.0 | -3.6 | 7.5 | 7.9 | 11.2 |
|
Company
|
2022
|
2021
|
|---|---|---|
|
Sema4 Holdings Corp. Class A (SMFR)
| -94.1 | -59.6 |
|
BSE Sensex
| 4.4 | 22.0 |
|
BSE Sensex
| 4.4 | 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sema4 Holdings Corp. Class A (SMFR)
|
0.4 | 120.1 | 234.7 | -549.0 | -253.4 | -171.1 | 1.6 | 0.2 |
| 13.9 | 3,186.8 | 3,125.0 | -262.7 | 0.9 | -313.2 | -- | 20.5 | |
| 377.6 | 5,278.0 | 2,530.0 | 265.2 | 14.2 | 25.3 | 20.1 | 5.3 | |
| 53.6 | 2,778.6 | 941.5 | 105.7 | 14.5 | 29.4 | 26.2 | 7.3 | |
| 97.4 | 9,812.1 | 5,935.2 | 566.2 | 18.1 | 25.1 | 17.6 | 3.9 | |
| 19.8 | 4,280.7 | 2,347.6 | 128.4 | 4.5 | 25.2 | 36.8 | 7.9 | |
| 26.5 | 4,285.8 | 5,649.5 | 207.6 | 7.0 | 15.2 | 21.3 | 3.3 | |
| 55.3 | 4,326.1 | 2,040.2 | -18.7 | 5.0 | -1.9 | -- | 4.0 | |
| 14.9 | 3,768.2 | 1,163.6 | 78.0 | 26.1 | 15.4 | 49.1 | 6.2 | |
| 200.1 | 11,646.4 | 5,057.8 | 344.0 | 9.2 | 16.9 | 34.4 | 5.2 |
Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that... delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services. It also offers Sema4 Signal that enables and advances precision oncology care, from prevention to treatment to remission; and testing for carrier screening, noninvasive prenatal testing, and newborn screening, as well as hereditary cancer testing. In addition, the company provides COVID-19 testing solutions. Sema4 Holdings Corp. was incorporated in 2020 and is headquartered in Stamford, Connecticut. Read more
Exec. Chair of the Board
Mr. Jason Ryan
Exec. Chair of the Board
Mr. Jason Ryan
Headquarters
Stamford, CT
Website
The share price of Sema4 Holdings Corp Class A (SMFR) is $0.36 (NASDAQ) as of 13-Mar-2023 09:30 EDT. Sema4 Holdings Corp Class A (SMFR) has given a return of -87.18% in the last 1 years.
The P/E ratio of Sema4 Holdings Corp Class A (SMFR) is 1.55 times as on 13-Mar-2023.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
-0.16
|
0.36
|
|
2021
|
-4.39
|
2.78
|
|
2020
|
-13,793.42
|
530.34
|
|
2019
|
--
|
--
|
|
2022
|
-0.16
|
0.36
|
The 52-week high and low of Sema4 Holdings Corp Class A (SMFR) are Rs -- and Rs -- as of 02-Apr-2026.
Sema4 Holdings Corp Class A (SMFR) has a market capitalisation of $ 120 Mln as on 13-Mar-2023. As per SEBI classification, it is a company.
Before investing in Sema4 Holdings Corp Class A (SMFR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.